- £978.54m
- £1.21bn
- £673.20m
- 96
- 21
- 66
- 69
Annual balance sheet for CVS, fiscal year end - June 30th, GBP millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 33.7 | 49 | 21.5 | 16.5 | 16.1 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 39.6 | 42.1 | 48.8 | 68.1 | 77.4 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 101 | 128 | 112 | 129 | 135 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 155 | 171 | 204 | 226 | 222 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 485 | 518 | 572 | 690 | 696 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 98.5 | 101 | 105 | 118 | 123 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 293 | 301 | 316 | 430 | 396 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 191 | 217 | 257 | 260 | 300 |
| Total Liabilities & Shareholders' Equity | 485 | 518 | 572 | 690 | 696 |
| Total Common Shares Outstanding |